T-Cell Receptor Vα Spectratype Analysis of a CD4-Mediated T-Cell Response against Minor Histocompatibility Antigens Involved in Severe Graft-versus-Host.

Slides:



Advertisements
Similar presentations
Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators  Shoshana.
Advertisements

Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C
Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation  Qing Ma, Dan Li, Roza Nurieva, Rebecca.
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation  Michael Weber,
William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D
Expression of Chemokines in GVHD Target Organs Is Influenced by Conditioning and Genetic Factors and Amplified by GVHR  Markus Y. Mapara, Corinna Leng,
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease  Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,
Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host Disease  Robert Zeiser,
A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation.
Identification of Stem Cell Transcriptional Programs Normally Expressed in Embryonic and Neural Stem Cells in Alloreactive CD8+ T Cells Mediating Graft-versus-Host.
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver  Alina Schreder,
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone.
T-Cell Receptor Vα Usage by Effector CD4+Vβ11+ T Cells Mediating Graft-versus-Host Disease Directed to Minor Histocompatibility Antigens  Christine G.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft- versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen–Disparate.
A Role for TNF Receptor Type II in Leukocyte Infiltration into the Lung during Experimental Idiopathic Pneumonia Syndrome  Gerhard C. Hildebrandt, Krystyna.
Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells  Allan D. Hess,
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)  Yehudith Azar, Reut.
Low c-Kit Expression Level Induced by Stem Cell Factor Does Not Compromise Transplantation of Hematopoietic Stem Cells  Chia-Ling Chen, Katerina Faltusova,
Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators  Shoshana.
Evelyn C. Nieves, Tomomi Toubai, Daniel C
Treatment with a Rho Kinase Inhibitor Improves Survival from Graft-Versus-Host Disease in Mice after MHC-Haploidentical Hematopoietic Cell Transplantation 
Graft-versus-Host Disease–Related Cytokine-Driven Apoptosis Depends on p73 in Cytokeratin 15–Positive Target Cells  Qian Zhan, Robert Korngold, Cecilia.
FTY720 Markedly Increases Alloengraftment but Does Not Eliminate Host Anti-Donor T Cells that Cause Graft Rejection on Its Withdrawal  Patricia A. Taylor,
Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal.
Keratinocyte Dysplasia in Hematopoietic Stem Cell Transplantation Recipients in the Day-28-to-84 Posttransplantation Period  Ning Li, Katherine A. Guthrie,
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Genital Chronic Graft-versus-Host Disease in Females: A Cross-Sectional Study  Eva Smith Knutsson, Yvonne Björk, Anna-Karin Broman, Lotti Helström, Anne-Marie.
Sequential Expression of Adhesion and Costimulatory Molecules in Graft-versus-Host Disease Target Organs after Murine Bone Marrow Transplantation across.
George F Murphy, Robert Korngold 
An Essential Role for IFN-γ in Regulation of Alloreactive CD8 T Cells Following Allogeneic Hematopoietic Cell Transplantation  Wannee Asavaroengchai,
Survival and Function of MiHA Epitope-Specific Host CD8 TM Cells Following Ablative Conditioning and HCT  Alwi M. Shatry, Derry C. Roopenian, Robert B.
Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels  Chien-Chun Steven.
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd  Bettina P. Iliopoulou, PhD, Katie Hsu, MS, Antonio Pierini, MD, Gordon J. Freeman,
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft- versus-Host Disease  Scott S. Graves, Maura H. Parker, Diane Stone,
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Lisa A. Palmer, George E. Sale, John I
Differential Expression of the Ly49GB6, but Not the Ly49GBALB, Receptor Isoform during Natural Killer Cell Reconstitution after Hematopoietic Stem Cell.
Absence of Cutaneous TNFα-Producing CD4+ T Cells and TNFα may Allow for Fibrosis Rather than Epithelial Cytotoxicity in Murine Sclerodermatous Graft-Versus-Host.
T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient.
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
Effector Cells Derived from Host CD8 Memory T Cells Mediate Rapid Resistance against Minor Histocompatibility Antigen-Mismatched Allogeneic Marrow Grafts.
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
Mammalian Target of Rapamycin Inhibitors Permit Regulatory T Cell Reconstitution and Inhibit Experimental Chronic Graft-versus-Host Disease  Haruko Sugiyama,
A CD4 Domain 1 CC′ Loop Peptide Analogue Enhances Engraftment in a Murine Model of Bone Marrow Transplantation with Sublethal Conditioning  Gabor Varadi,
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Treatment with GM-CSF Secreting Myeloid Leukemia Cell Vaccine Prior to Autologous- BMT Improves the Survival of Leukemia-Challenged Mice  Jenny Zilberberg,
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction  Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.
The Innate Immune Sensor Sting Can Augment or Ameliorate Graft-Versus-Host Disease Dependent on the Genetic Disparity between Donors and Recipients  Cameron.
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation  Jian-Ming Li, Edmund K.
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response 
Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg 
Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation:
Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either.
Specific donor Vβ-associated CD4+ T-cell responses correlate with severe acute graft- versus-host disease directed to multiple minor histocompatibility.
An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression  Diana.
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect  Shawn G Clouthier,
Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution  Maria Gendelman, Maryam Yassai,
Induction of Lethal Graft-versus-Host Disease by Anti-CD137 Monoclonal Antibody in Mice Prone to Chronic Graft-versus-Host Disease  Wonyoung Kim, Juyang.
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice  Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.
Volume 37, Issue 2, Pages (August 2012)
Presentation transcript:

T-Cell Receptor Vα Spectratype Analysis of a CD4-Mediated T-Cell Response against Minor Histocompatibility Antigens Involved in Severe Graft-versus-Host Disease  Christine G. DiRienzo, George F. Murphy, Stephen C. Jones, Robert Korngold, Thea M. Friedman  Biology of Blood and Marrow Transplantation  Volume 12, Issue 8, Pages 818-827 (August 2006) DOI: 10.1016/j.bbmt.2006.05.002 Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 GVHD potential of Vβ11-enriched B6 CD4+ T cells. (A) BALB.B mice were lethally irradiated (13 Gy, split dose) and injected with 2×106 B6 ATBM cells alone or in combination with either 2 × 107 unfractionated B6 CD4+ T cells or 5.6 × 105 CD4+Vβ11+ enriched 83.7% double-positive B6 T cells. (B) Survival of transplanted recipients. (C) Body weights for each group normalized as the mean percentage of initial body weight. Data are from a single experiment, representative of the 3 experiments performed. BALB.B receiving unfractionated B6 CD4+ T cells (n = 3) or CD4+Vβ11+ T cells (n = 5) versus B6 ATBM (n = 3); P ≤ .001. Biology of Blood and Marrow Transplantation 2006 12, 818-827DOI: (10.1016/j.bbmt.2006.05.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Immunohistochemical identification of B6 Vβ11+ T cells infiltrating BALB.B lingual epithelium. Lingual epithelium of lethally irradiated (8.5 Gy) BALB.B recipients, 9 days after transplantation with either 2 × 106 B6 ATBM cells, alone (A), or along with 1.8 × 107 unfractionated B6 CD4+ T cells (B), 7 × 105 B6 CD4+Vβ11+ T cells (C), or 7 × 105 B6 CD4+Vβ11− T cells (D). Arrows denote examples of cells that stained with the anti-Vβ11 mAb procedure, which was apparent only in recipients receiving unfractionated CD4+ or Vβ11+ T cells, with apposition of effector cells primarily evident at this time point to the dermis and basal layers. Tissues were from a single mouse, representative of each group (n = 3), and from a total of 3 similar experiments. Biology of Blood and Marrow Transplantation 2006 12, 818-827DOI: (10.1016/j.bbmt.2006.05.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Immunohistochemical identification of B6 Vβ11+ T cells infiltrating BALB.B crypts of the small intestine. Crypts of lethally irradiated (8.5 Gy) BALB.B recipients 9 days after transplantation with either 2 × 106 B6 ATBM cells alone (A) or along with 1.8 × 107 unfractionated B6 CD4+ T cells (B), 7 × 105 B6 CD4+Vβ11+ T cells (C), or 7 × 105 B6 CD4+Vβ11− T cells (D). Arrows denote examples of cells that stained with the anti-Vβ11 mAb procedure, which was apparent only in recipients receiving unfractionated CD4+ or Vβ11+ T cells. Infiltration and architectural disruption of crypt epithelium are evident and cells in the lamina propria are also of note. Tissues were from a single mouse, representative of each group (n = 3), and from a total of 3 similar experiments. Biology of Blood and Marrow Transplantation 2006 12, 818-827DOI: (10.1016/j.bbmt.2006.05.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Apoptotic injury in lingual and intestinal tissue. BALB.B mice were irradiated (8.5 Gy) and injected i.v. with 2 × 106 B6 ATBM cells along with 7 × 105 B6 CD4+Vβ11+ T cells. Analysis of relative apoptotic injury (black bars) and Vβ11+ T-cell infiltration (white bars) was performed at days 10 and 15 on tissue samples of tongue and small intestine. In the tongue, the number of apoptotic cells per linear mm in rete ridge-like prominences significantly increased by day 15, whereas the total number of T cells, including the Vβ11+ T cells, in the entire epithelium was already diminishing by this time point. In the small intestine, both the number of apoptotic cells and infiltrating Vβ11+ T cells per crypt were elevated by day 15. Apoptotic cells were enumerated using conventional light microscopy, based on the criteria of nuclear condensation and/or fragmentation and cytoplasmic hypereosinophilia. Vβ11+ T cells were enumerated through standard cell counting methods for immunohistochemical preparations. Where feasible, at least 20 linear mm of lingual epithelium and 50 crypts were evaluated per animal (n = 5) and the mean values expressed (SEM ≤ 10%). Biology of Blood and Marrow Transplantation 2006 12, 818-827DOI: (10.1016/j.bbmt.2006.05.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 TCR Vα histograms from a population of normal B6 CD4+Vβ11+ T cells. B6 CD4+ T cells were prepared from a pool of lymphocytes from 20 B6 mice and were positively selected by magnetic cell separation based on cell surface expression of Vβ11. RNA was extracted from Vβ11+-enriched cells, and RT-PCR was performed using 22 TCR Vα-specific primers. Histograms are shown for each of the TCR Vα families amplified and are representative results from 3 separate experiments. Biology of Blood and Marrow Transplantation 2006 12, 818-827DOI: (10.1016/j.bbmt.2006.05.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 TCR Vα histograms from a population of B6 anti-BALB.B CD4+Vβ11+ T cells. BALB.B-presensitized unfractionated B6 CD4+ T cells were injected IV into lethally irradiated BALB.B mice. Ten days later, spleens and LN were harvested from BALB.B recipients, and CD4+Vβ11+ T cells were positively selected by magnetic cell separation. RNA was extracted from Vβ11+-enriched cells, and RT-PCR was performed using 22 TCR Vα-specific primers. Histograms are shown for each of the skewed TCR Vα families amplified and are representative results from 3 separate experiments. Biology of Blood and Marrow Transplantation 2006 12, 818-827DOI: (10.1016/j.bbmt.2006.05.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions